Four cases of cholesterol management informed by the 2018 American Heart Association/American College of Cardiology multisociety guideline on the management of blood cholesterol
Document Type
Article
Department
Cardiology; Office of the Provost
Abstract
These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines.
Publication (Name of Journal)
JAMA Cardiology
DOI
10.1001/jamacardio.2019.0771
Recommended Citation
Chuzi, S.,
Pfenniger, A.,
Lloyd-Jones, D. M.,
Blumenthal, R. S.,
Smith, S. C.,
Virani, S. S.,
Grundy, S. M.,
Stone, N. J.
(2019). Four cases of cholesterol management informed by the 2018 American Heart Association/American College of Cardiology multisociety guideline on the management of blood cholesterol. JAMA Cardiology, 4(5), 473-477.
Available at:
https://ecommons.aku.edu/provost_office/655
Comments
This work was published before the author joined Aga Khan University.